SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General issues related to the Medicare Part D program
Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so too Sanofi SA, as the parent corporation, will benefit..
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| TIMOTHY CLARK | — |
| MARYANNE DOLBEARE DUNLAP | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
Medical/Disease Research/Clinical Labs MED
General discussions regarding the reauthorization of the Prescription Drug User Fee Act (PDUFA); and education and awareness of vaccine production and infrastructure needs
Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so too Sanofi SA, as the parent corporation, will benefit..
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| TIMOTHY CLARK | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
Taxation/Internal Revenue Code TAX
Extension of the U.S. R&D tax credit and all such provisions in HR942 "The American Research and Competitiveness Act of 2011"
Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so too Sanofi SA, as the parent corporation, will benefit..
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
| ANN TAYLOR | — |
Copyright/Patent/Trademark CPT
HR 1249 "America Invents Act" provisions related to first to file, inter parties review and supplemental re-examination; intellectual property provisions in the pending South Korea, Columbia and Panama Free Trade Agreements
Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so too Sanofi SA, as the parent corporation, will benefit..
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| TIMOTHY CLARK | — |
| MARYANNE DOLBEARE DUNLAP | — |
| EDDIE D EVANS | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
Health Issues HCR
Repeal and defunding efforts and general issues regarding implementation of Public Law 111-148 "Patient Protection and Affordable Care Act" including all provisions of HR605 and S312 "Patients' Freedom to Choose Act," the Medication Therapy Management Program, transitions of care, and the Independent Payment Advisory Board (IPAB); awareness and issues related to patient access to diabetes care; awareness & issues related to patient access to atrial fibrillation care, including all provisions in HRes295 "Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease", issues related to efforts to move pseudoephedrine products to prescription drug status; education and awareness of influenza pandemic and biodefense funding in FY2012 funding bills; intellectual propterty issues in the WHO global pandemic vaccine allocation plans; education and awareness and general issues related to the reauthorization of the Pandemic and All Hazards Preparation Act; education and awareness of the company's global Access to Medicines Program; education and awareness of dengue; issues related to the Section 317 Program for vaccines; general issues related to prescription drug safety; and all provisions of S1002 "Safe Doses Act".
Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so too Sanofi SA, as the parent corporation, will benefit..
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| TIMOTHY CLARK | — |
| MARYANNE DOLBEARE DUNLAP | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
| ANN TAYLOR | — |
Torts TOR
Punitive damages provisions in HR5 "Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act; and general issues related to efforts to reform the Vaccine Injury Compensation Program.
Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so too Sanofi SA, as the parent corporation, will benefit..
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN | — |
| ANN TAYLOR | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SANOFI SA (FORMERLY SANOFI-AVENTIS SA) | France | France | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.